中老年人的心脏代谢疾病,认知衰退和大脑结构
Abigail Dove1, Jie Guo1, Jiao Wang2
1Aging Research Center Department of Neurobiology Care Sciences and Society Karolinska Institutet Stockholm Sweden.
Alzheimer's & dementia (Amsterdam, Netherlands)
|April 10, 2024
概括
多种心脏代谢疾病 (CMD) 加快了老年人的认知衰退,甚至在中年时也会对大脑结构产生负面影响. 这突显了代谢健康和认知衰老之间的关键联系.
科学领域:
- 神经科学是一个神经科学.
- 老年学是指老年学的学科.
- 心脏病学 心脏病学
背景情况:
- 多重心脏代谢疾病 (CMD) 与痴呆风险增加有关.
- 疾病对整个生命的认知和大脑结构的综合影响仍然不清楚.
研究的目的:
- 调查CMD数量与认知衰退之间的关联.
- 使用MRI检查CMD和大脑结构变化之间的关系.
主要方法:
- 分析了来自46 562名没有痴呆症的参与者的英国生物库数据.
- 在基线和9年后的认知测试;大脑MRI对39,306名参与者.
- 用混合效应模型和线性回归来进行年龄分层分析 (中年与老年).
主要成果:
- 较高的CMD负担与老年人 (≥60岁) 的全球认知衰退相关.
- 多重心血管疾病与大脑总体体积,灰质,白质和海马体积的减少有关.
- 在患有多种心血管疾病的参与者中,即使在中年 (<60岁) 中,也观察到白质过强度体积增加.
结论:
- 慢性脑疾病与老年人的加速认知衰退有关.
- 较差的大脑结构健康,包括大脑体积减少和白质强度增加,与中年开始的CMD有关.
- 这些发现强调了心脏代谢健康与认知/大脑衰老之间的联系.
相关概念视频
Cognitive Development During Adulthood
94
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
94
Aging
49
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
49
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Psychoneuroimmunology: Diabetes and Cancer
28
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
28
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
122
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
122


